Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000059478-25-000161
Filing Date
2025-06-06
Accepted
2025-06-06 16:11:11
Documents
5
Period of Report
2025-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1749240662.html 3  
1 FORM 3 wk-form3_1749240662.xml 3 7876
2 EX-24 kennethcuster-secpoasign.htm EX-24 1254
3 kennethcuster-secpoasign001.jpg GRAPHIC 184443
4 kennethcuster-secpoasign002.jpg GRAPHIC 165144
5 kennethcuster-secpoasign003.jpg GRAPHIC 69063
  Complete submission text file 0000059478-25-000161.txt   587550
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Issuer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ELI LILLY AND COMPANY 893 S DELAWARE STREET INDIANAPOLIS IN 46225
Business Address
Custer Kenneth L. (Reporting) CIK: 0002071542 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06351 | Film No.: 251030766